Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220645
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cash flows from investing activities: | ||
| Purchases of marketable securities | (162,206) | (6,870) |
| Maturities of marketable securities | 42,050 | 38,910 |
| Purchases of property and equipment | (88) | (14) |
| Net cash provided by (used in) investing activities | (120,244) | 32,026 |
| Cash flows from financing activities: | ||
| Proceeds from issuances of common stock under benefit plans | 12,530 | 2,187 |
| Proceeds from issuances of common stock under at-the-market offering program, net of $2.1 million of issuance costs | 147,853 | — |
Item 1. Condensed Financial Statements
FAQ
- What is Tyra Biosciences, Inc.'s capex?
- Tyra Biosciences, Inc. (TYRA) reported capex of $88K in Q1 2026.
- How has Tyra Biosciences, Inc.'s capex changed year-over-year?
- Tyra Biosciences, Inc.'s capex increased by 528.6% year-over-year, from $14K to $88K.
- What is the long-term trend for Tyra Biosciences, Inc.'s capex?
- Over 4 years (2021 to 2025), Tyra Biosciences, Inc.'s capex has grown at a -32.0% compound annual growth rate (CAGR), from $661K to $141K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Tyra Biosciences, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude